Related Experiment Video

Updated: May 28, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
05:51

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain

Published on: July 24, 2016

Caffey's disease in an infant

Afsheen Batool Raza1, Iftikhar Ijaz, Farrah Naz

  • 1Department of Paediatric Medicine, The Children's Hospital and The Institute of Child Health, 13 Danepur Road, Lahore. dr.afsheenrazapaeds@gmail.com

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
|October 22, 2011
PubMed

Insights

Caffey's disease, also known as infantile cortical hyperostosis, is a rare condition in infants. This case report details a 4-month-old infant diagnosed with Caffey's disease and treated successfully with symptomatic management.

Area of Science:

  • Pediatrics
  • Rare Diseases
  • Skeletal Dysplasias

Background:

  • Caffey's disease, or infantile cortical hyperostosis, is a self-limiting infantile disorder.
  • It is characterized by fever, irritability, bone pain, and distinctive bone abnormalities.
  • The exact etiology of Caffey's disease remains unknown.

Observation:

  • This report focuses on a 4-month-old infant presenting with symptoms of fever, irritability, and soft tissue swellings.
  • Diagnostic investigations were conducted to identify the cause of the infant's symptoms.

Findings:

  • The infant was diagnosed with Caffey's disease based on clinical presentation and investigations.
  • The characteristic bony changes associated with the condition were identified.

Implications:

  • This case highlights the importance of recognizing Caffey's disease in infants with unexplained fever and swelling.
  • Symptomatic treatment proved effective, leading to a good clinical response.
  • Further research into the etiology of Caffey's disease may improve diagnostic and therapeutic strategies.

More Related Videos

A Ferret Model of Inflammation-sensitized Late Preterm Hypoxic-ischemic Brain Injury07:36

A Ferret Model of Inflammation-sensitized Late Preterm Hypoxic-ischemic Brain Injury

Published on: November 19, 2019

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development08:50

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development

Published on: June 24, 2020

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...